The current study demonstrates the protective potential of Nicorandil (NIC) in alleviating liver fibrosis induced by TAA in rats, with a particular focus on the modulation of the AMPK/SIRT-1/HIF-1α signaling axis. This evidence concerns the gene HIF1A and Hepatic fibrosis.